On July 7, Ping An Good Doctor (01833.HK) declined 5.13% in regular trading, trading at HK$7.24 per share, with turnover of approximately HK$52.58 million.

On the news front, the latest disclosure from the Hong Kong Stock Exchange revealed that Morgan Stanley significantly reduced its long position in Ping An Good Doctor from 8.02% to 5.88%, while its short position also declined from 7.48% to 5.42%, reflecting a systematic scaling back of exposure to the company. Meanwhile, market skepticism over the company's excessive reliance on the Ping An Group ecosystem has intensified, with analysts noting that key services such as its family doctor offering remain fundamentally dependent on the group's traffic pool, raising doubts about independent revenue generation capabilities. Additionally, CFO Zang Luoqi resigned on June 16, with frequent senior management turnover further exacerbating market unease.

Morgan Stanley had previously maintained a target price of HK$16.8 for the stock following its Q1 results, which showed revenue growth of 9.1% year-over-year and adjusted net profit growth of 45.8%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)